UPDATE 1-AstraZeneca sees fall in 2016 earnings as Crestor loss weighs

* Q4 revenue $6.40 billion vs consensus $6.29 billion (Adds CEO comment, details)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.